BioCentury | Jan 10, 2005
Company News

Sangamo management update

...Business: Cardiovascular, Cancer, Neurology Hired: David Ichikawa as SVP of business development, formerly CBO of Sagres Discovery...
BioCentury | Oct 8, 2004
Financial News

Chiron trims GAAP guidance

...amortization expense related to the acquisitions of PathoGenesis ; Chiron Behring; Pulmopharm; PowderJect ; and Sagres...
BioCentury | Jul 12, 2004
Strategy

Two ends against the middle

...Although Chiron Corp. 's acquisition of Sagres Discovery Inc. doesn't remedy its thin clinical pipeline in cancer...
...the deal lays the foundation for a renewable internal source of oncology compounds. In addition, Sagres'...
...companies that use expression data to infer whether a gene may be a good target. Sagres'...
BioCentury | Jul 12, 2004
Company News

Chiron, Sagres Discovery Inc. deal

...CHIR acquired cancer target company Sagres for an undisclosed sum. Sagres uses its Oncogenome high throughput...
...XOMA, Berkeley, Calif.) to develop antibodies against targets from CHIR. Chiron Corp. (CHIR), Emeryville, Calif. Sagres Discovery...
BioCentury | Jul 12, 2004
Company News

Guava management update

...David Ferrick as VP of biology and clinical applications, formerly CEO and a director at Sagres Discovery...
BioCentury | Jul 6, 2004
Top Story

Chiron acquires Sagres

...CHIR acquired cancer target company Sagres (Davis, Calif.) for an undisclosed sum. Sagres is using its...
BioCentury | Nov 10, 2003
Company News

Sagres scientific advisory board update

...biology at the Scripps Research Institute, as chairman; Ali Fattaey, SVP of discovery research at Sagres...
BioCentury | May 26, 2003
Emerging Company Profile

Corporate Profile

Sagres Discovery Inc. Davis, Calif. Technology: High throughput insertional mutagenesis Disease focus: Cancer Clinical status: Discovery Founded: 2000 by David Morris; Michael Miille; Marc Malandro; David Ferrick; Matthias Wabl Corporate partners: Boehringer Ingelheim GmbH University...
BioCentury | May 26, 2003
Emerging Company Profile

Sagres: Sifting wheat from chaff

...state. Such is the obstacle in comparing cancerous and healthy tissue. To solve that problem, Sagres Discovery...
...mutagenesis using a retrovirus to identify causative cancer genes - and made it high throughput. Sagres'...
...Sagres expects to retain the MemRx staff and maintain the research operation in San Diego. Sagres...
BioCentury | Apr 7, 2003
Company News

MemRx Corp., Sagres deal

...Sagres will acquire protein structure-based drug discovery company MemRx. The equity-based deal combines Sagres' Oncogenome collection...
...determining the structures of membrane-bound protein targets, including G protein-coupled receptors (GPCRs) and ion channels. Sagres...
...staff and maintain the research operation in San Diego. MemRx Corp. , San Diego, Calif. Sagres Discovery...
Items per page:
1 - 10 of 22
BioCentury | Jan 10, 2005
Company News

Sangamo management update

...Business: Cardiovascular, Cancer, Neurology Hired: David Ichikawa as SVP of business development, formerly CBO of Sagres Discovery...
BioCentury | Oct 8, 2004
Financial News

Chiron trims GAAP guidance

...amortization expense related to the acquisitions of PathoGenesis ; Chiron Behring; Pulmopharm; PowderJect ; and Sagres...
BioCentury | Jul 12, 2004
Strategy

Two ends against the middle

...Although Chiron Corp. 's acquisition of Sagres Discovery Inc. doesn't remedy its thin clinical pipeline in cancer...
...the deal lays the foundation for a renewable internal source of oncology compounds. In addition, Sagres'...
...companies that use expression data to infer whether a gene may be a good target. Sagres'...
BioCentury | Jul 12, 2004
Company News

Chiron, Sagres Discovery Inc. deal

...CHIR acquired cancer target company Sagres for an undisclosed sum. Sagres uses its Oncogenome high throughput...
...XOMA, Berkeley, Calif.) to develop antibodies against targets from CHIR. Chiron Corp. (CHIR), Emeryville, Calif. Sagres Discovery...
BioCentury | Jul 12, 2004
Company News

Guava management update

...David Ferrick as VP of biology and clinical applications, formerly CEO and a director at Sagres Discovery...
BioCentury | Jul 6, 2004
Top Story

Chiron acquires Sagres

...CHIR acquired cancer target company Sagres (Davis, Calif.) for an undisclosed sum. Sagres is using its...
BioCentury | Nov 10, 2003
Company News

Sagres scientific advisory board update

...biology at the Scripps Research Institute, as chairman; Ali Fattaey, SVP of discovery research at Sagres...
BioCentury | May 26, 2003
Emerging Company Profile

Corporate Profile

Sagres Discovery Inc. Davis, Calif. Technology: High throughput insertional mutagenesis Disease focus: Cancer Clinical status: Discovery Founded: 2000 by David Morris; Michael Miille; Marc Malandro; David Ferrick; Matthias Wabl Corporate partners: Boehringer Ingelheim GmbH University...
BioCentury | May 26, 2003
Emerging Company Profile

Sagres: Sifting wheat from chaff

...state. Such is the obstacle in comparing cancerous and healthy tissue. To solve that problem, Sagres Discovery...
...mutagenesis using a retrovirus to identify causative cancer genes - and made it high throughput. Sagres'...
...Sagres expects to retain the MemRx staff and maintain the research operation in San Diego. Sagres...
BioCentury | Apr 7, 2003
Company News

MemRx Corp., Sagres deal

...Sagres will acquire protein structure-based drug discovery company MemRx. The equity-based deal combines Sagres' Oncogenome collection...
...determining the structures of membrane-bound protein targets, including G protein-coupled receptors (GPCRs) and ion channels. Sagres...
...staff and maintain the research operation in San Diego. MemRx Corp. , San Diego, Calif. Sagres Discovery...
Items per page:
1 - 10 of 22